Monday, December 23, 2024
HomeTagsIdorsia

Idorsia

Idorsia U.S. Announces First Wave of Patients Prescribed QUVIVIQ (daridorexant) through Partnership with Pharmacy Services Provider

Following the launch of QUVIVIQ™ (daridorexant) CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced that the first wave of patients has been prescribed...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics